Cargando…
Overcoming roadblocks in the development of vaccines for leishmaniasis
INTRODUCTION: The leishmaniases represent a group of parasitic diseases caused by infection with one of several species of Leishmania parasites. Disease presentation varies because of differences in parasite and host genetics and may be influenced by additional factors such as host nutritional statu...
Autores principales: | Kaye, Paul M., Mohan, Sakshi, Mantel, Carsten, Malhame, Melissa, Revill, Paul, Le Rutte, Epke, Parkash, Vivak, Layton, Alison M., Lacey, Charles J.N., Malvolti, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844205/ https://www.ncbi.nlm.nih.gov/pubmed/34727814 http://dx.doi.org/10.1080/14760584.2021.1990043 |
Ejemplares similares
-
Human leishmaniasis vaccines: Use cases, target population and potential global demand
por: Malvolti, Stefano, et al.
Publicado: (2021) -
Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates
por: Mohan, Sakshi, et al.
Publicado: (2022) -
Vaccines against leishmaniasis: using controlled human infection models to accelerate development
por: Parkash, Vivak, et al.
Publicado: (2021) -
The potential impact of human visceral leishmaniasis vaccines on population incidence
por: Le Rutte, Epke A., et al.
Publicado: (2020) -
Assessing public perception of a sand fly biting study on the pathway to a controlled human infection model for cutaneous leishmaniasis
por: Parkash, Vivak, et al.
Publicado: (2021)